NOUMAN ASIF M.D. NPI 1790947174

NPI Details

Nouman Asif, M.D. is a hematology and oncology internal medicine in Rehoboth Beach, DE with 15 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Nouman Asif, M.D. NPI is 1790947174. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

18947 JOHN J WILLIAMS HWY
REHOBOTH BEACH, DE
ZIP 19971-474
Phone: (302) 645-3770
Fax: (302) 645-5718

The NPI 1790947174 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Ferritin (blood protein) level (HCPCS:82728)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Measurement of substance using immunoassay technique (HCPCS:83520)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Unclassified drugs (HCPCS:J3490)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Drawing of blood for a medical problem (HCPCS:99195)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Blood test, clotting time (HCPCS:85610)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Folic acid level, serum (HCPCS:82746)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Injection of drug or substance into vein (HCPCS:96374)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Uric acid level, blood (HCPCS:84550)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)

The enumeration date for this NPI number is 6/27/2008 and was last updated on 12/21/2011.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: